UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000029800
Receipt No. R000034027
Official scientific title of the study Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis with Endoscopically Normal Mucosa
Date of disclosure of the study information 2017/11/03
Last modified on 2017/11/02 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis with Endoscopically Normal Mucosa
Title of the study (Brief title) Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis with Endoscopically Normal Mucosa
Region
Japan

Condition
Condition Ulcerative colitis
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate histological risk factors for clinical relapse in UC patients with endoscopically mucosal healing.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Presence or absence of clinical relapse and time to relapse
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Patients with UC who underwent colonoscopy with biopsies at Kitasato University Kitasato Institute Hospital between April 2012 and May 2016 and endoscopically confirmed Mayo Endoscopic Subscore 0 or 1
Key exclusion criteria Exacerbations due to infectious gastroenteritis and those complicated with other diseases are excluded from relapses.
Target sample size 150

Research contact person
Name of lead principal investigator Taku Kobayashi
Organization Kitasato University Kitasato Institute Hospital
Division name Center for Advanced IBD Research and Treatment
Address 5-9-1 Shirokane, Minato-ku, Tokyo
TEL 03-3444-6161
Email kobataku@insti.kitasato-u.ac.jp

Public contact
Name of contact person Ryo Ozaki
Organization Kitasato University Kitasato Institute Hospital
Division name Center for Advanced IBD Research and Treatment
Address 5-9-1 Shirokane, Minato-ku, Tokyo
TEL 03-3444-6161
Homepage URL
Email deka404@gmail.com

Sponsor
Institute Kitasato University Kitasato Institute Hospital
Institute
Department

Funding Source
Organization Kitasato University Kitasato Institute Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 11 Month 03 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 04 Month 01 Day
Anticipated trial start date
2017 Year 05 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Clinical course until October 2016 was reviewed to assess the association of endoscopic or histological findings and time to clinical relapse. All data were retrospectively collected from the electric medical record (database on the histological diagnosis was prospectively recorded). All endoscopic procedures were performed by the expert gastroenterologists.Biopsies were taken from the rectum or from the colonic mucosa with endoscopically most severe inflammation. All histopathological diagnoses were made by 2 expert pathologists.

Management information
Registered date
2017 Year 11 Month 02 Day
Last modified on
2017 Year 11 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034027